Topical immunosuppressants for blepharitis in adults

Area of Science:

• Ophthalmology
• Dermatology
• Immunology

Background:

• Blepharitis is a common eyelid inflammation causing discomfort and ocular surface damage.
• Conventional treatments include eyelid hygiene and artificial tears.
• Topical corticosteroids are used for inflammation but have side effects; newer immunosuppressants are alternatives.

Purpose of the Study:

• To evaluate the efficacy and safety of topical immunosuppressants for adult blepharitis.
• To compare immunosuppressants against placebo, conventional treatments, or other immunosuppressants.

Main Methods:

• Systematic review and meta-analysis of 12 randomized controlled trials (RCTs).
• Included 2752 participants comparing topical corticosteroids, cyclosporine, or tacrolimus.
• Assessed outcomes including symptom scores, tear film breakup time, corneal staining, and adverse effects.

Main Results:

• Topical corticosteroids and cyclosporine showed little to no significant difference in symptom reduction compared to placebo or antibiotics.
• Topical corticosteroids with antibiotics may improve corneal staining more than antibiotics alone.
• Evidence for tear breakup time and symptom scores was very uncertain or inconclusive for most comparisons.

Conclusions:

• Topical immunosuppressants offer limited benefits for blepharitis symptoms at 4-12 weeks.
• Topical corticosteroids are generally well-tolerated with minimal irritation.
• Conventional treatments like lid hygiene remain important therapeutic options due to limited evidence for newer agents.